Viewing StudyNCT00169169



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00169169
Status: TERMINATED
Last Update Posted: 2005-09-15
First Post: 2005-09-13

Brief Title: Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
Sponsor: Lymphoma Study Association
Organization: Lymphoma Study Association

Conditions & Keywords Data

Conditions:
Name
CD20-Positive Large B-Cell Lymphoma
Keywords:
Name View
Autotransplant View
Diffuse large B cell lymphoma View
Rituximab View